N. Suehara et al., TELOMERASE ELEVATION IN PANCREATIC DUCTAL CARCINOMA COMPARED TO NONMALIGNANT PATHOLOGICAL STATES, Clinical cancer research, 3(6), 1997, pp. 993-998
Telomerase activity was measured in surgically resected tissues of 20
human pancreatic ductal carcinomas, 12 adenomas, 5 pancreatitis tissue
s, 14 normal pancreatic ducts, and 13 normal pancreatic tissues (prima
rily made up of acinar cells) using a PCR-based telomerase assay, Rela
tive telomerase activity was expressed as the equivalent telomerase in
tensity of the number of cells of a human pancreatic cancer cell line,
MIA PaCa-2, per microgram of protein in the tissue samples, The media
n value (25th percentile, 75th percentile) of relative telomerase acti
vity in pancreatic carcinomas was 13.2 (3.58, 244), which was signific
antly higher relative to normal tissues, normal ducts, pancreatitis ti
ssues, and adenomas (P < 0.0001), When the cutoff value of relative te
lomerase activity was set at 1.00 and 3.00, the positivity rates of te
lomerase activity in pancreatic ductal carcinomas were 100 and 80%, re
spectively, Some of the adenoma samples displayed a weak telomerase la
dder, However, when semiquantitatively analysed, the relative telomera
se activity of all adenoma tissues was less than 1.00 equivalent cells
per microgram protein of the tissues, which was equivalent to the val
ues encountered in normal ducts, Thus, our results indicate that react
ivation of telomerase may occur at a late stage of pancreatic ductal c
arcinogenesis, Therefore, telomerase may be a specific marker for dist
inguishing pancreatic cancer from pancreatitis and adenomas.